AssetMark Inc
BNTX icon

AssetMark Inc’s BioNTech BNTX Stock Holding History

AssetMark Inc’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.21K Buy
99
+38
+62% +$3.58K ﹤0.01% 2480
2026
Q1 		$5.42K Sell
61
-2
-3% -$206 ﹤0.01% 2536
2025
Q4 		$6K Buy
63
+5
+9% +$504 ﹤0.01% 2407
2025
Q3 		$5.72K Buy
58
+24
+71% +$2.57K ﹤0.01% 2303
2025
Q2 		$3.62K Buy
34
+14
+70% +$1.41K ﹤0.01% 2238
2025
Q1 		$1.82K Hold
20
– – ﹤0.01% 2193
2024
Q4 		$2.28K Hold
20
– – ﹤0.01% 2090
2024
Q3 		$2.38K Hold
20
– – ﹤0.01% 1851
2024
Q2 		$1.61K Hold
20
– – ﹤0.01% 1780
2024
Q1 		$1.84K Sell
20
-28
-58% -$2.69K ﹤0.01% 1593
2023
Q4 		$5.07K Sell
48
-1,976
-98% -$199K ﹤0.01% 1447
2023
Q3 		$220K Sell
2,024
-55
-3% -$6.08K ﹤0.01% 855
2023
Q2 		$224K Buy
2,079
+309
+17% +$34.8K ﹤0.01% 828
2023
Q1 		$220K Buy
1,770
+423
+31% +$58.1K ﹤0.01% 816
2022
Q4 		$202K Buy
1,347
+74
+6% +$11.4K ﹤0.01% 817
2022
Q3 		$172K Sell
1,273
-38
-3% -$5.81K ﹤0.01% 783
2022
Q2 		$195K Buy
1,311
+40
+3% +$6.11K ﹤0.01% 743
2022
Q1 		$217K Sell
1,271
-233
-15% -$39.2K ﹤0.01% 718
2021
Q4 		$388K Buy
1,504
+1,430
+1,932% +$392K ﹤0.01% 586
2021
Q3 		$20K Buy
+74
New +$23.5K ﹤0.01% 934

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

AssetMark Inc's BNTX Position: Q2 2026 in Review

AssetMark Inc increased its BioNTech (BNTX) stake by 62% in Q2 2026, buying an estimated $3.58K and bringing the position to 99 shares worth $9.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

AssetMark Inc first reported a position in BNTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $388K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • AssetMark Inc held 99 shares of BioNTech worth $9.21K as of Q2 2026.
  • AssetMark Inc bought 38 BioNTech shares in Q2 2026, an estimated $3.58K.
  • BioNTech made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2480 holding.
  • AssetMark Inc first reported a position in BioNTech in Q3 2021 and has held it in 20 quarters since.
  • AssetMark Inc's BioNTech position peaked at $388K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.